Clover Health Investments Corp.
Organization details
- Legal name
- Clover Health Investments Corp.
- Former names
- Social Capital Hedosophia Holdings Corp. III
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Financials
- SIC code
- 6324 — Hospital & Medical Service Plans
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Jersey City
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CLOV
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001801170
- EIN
- 98-1515192
Board of directors
-
Andrew Toy · Director · Chief Executive OfficerSince 2023
-
Anna U. Loengard · DirectorSince 2022
-
Brian James Miller · DirectorSince 2026
-
Carladenise Armbrister Edwards · DirectorSince 2023
-
Chelsea Clinton · DirectorSince 2023
-
Demetrios L. Kouzoukas · DirectorSince 2023
-
Lee Shapiro · DirectorSince 2023
-
Robert G. Torricelli · DirectorSince 2026
-
Thomas L. Tran · DirectorSince 2024
-
Vivek Garipalli · Director · Executive ChairpersonSince 2023
-
William G. Robinson Jr. · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.3%
-
98.9%
-
99.7%
Board connections
2 of this board's directors also sit on 3 other boards.
- via William G. Robinson Jr.
- via Chelsea Clinton
- via Chelsea Clinton
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $8,821,159
- 42 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 16, 2026 | THORNTON JOSEPH CLAY Officer (Chief Financial Officer) | Open-market sale | −22,099 | $4.97 | $109,832 |
| Nov 4, 2026 | THORNTON JOSEPH CLAY Officer (Chief Financial Officer) | Grant or award | +328,947 | — | — |
| Nov 4, 2026 | OLDAKOWSKI JOSEPH FRANK Officer (Chief Accounting Officer) | Grant or award | +186,403 | — | — |
| Oct 20, 2026 | Soares Karen Officer (Chief Legal Officer) | Open-market sale | −19,275 | $4.66 | $89,822 |
| Oct 19, 2026 | Reynoso Jamie L. Officer (CEO, Medicare Advantage) | Open-market sale | −4,066 | $4.41 | $17,931 |
| Oct 15, 2026 | Reynoso Jamie L. Officer (CEO, Medicare Advantage) | Open-market sale | −18,273 | $4.68 | $85,518 |
| Oct 15, 2026 | Wai Conrad Officer (CEO, Counterpart Health) | Open-market sale | −23,627 | $4.68 | $110,574 |
| Oct 15, 2026 | THORNTON JOSEPH CLAY Officer (Interim CFO) | Open-market sale | −4,591 | $4.68 | $21,486 |
| Oct 15, 2026 | Soares Karen Officer (Chief Legal Officer) | Open-market sale | −14,673 | $4.68 | $68,670 |
| Oct 15, 2026 | Andrew Toy Director, Officer (Chief Executive Officer) | Open-market sale | −62,176 | $4.68 | $290,984 |
| Oct 7, 2026 | Reynoso Jamie L. Officer (CEO, Medicare Advantage) | Open-market sale | −2,006 | $4.63 | $9,288 |
| Oct 5, 2026 | Reynoso Jamie L. Officer (CEO, Medicare Advantage) | Open-market sale | −8,750 | $4.42 | $38,675 |
| Oct 1, 2026 | Andrew Toy Director, Officer (Chief Executive Officer) | Open-market sale | −318,806 | $4.19 | $1,335,797 |
| Sep 30, 2026 | Robert G. Torricelli Director | Grant or award | +12,481 | — | — |
| Sep 30, 2026 | Brian James Miller Director | Grant or award | +12,481 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Clover Health Investments Corp.
Who is the CEO of Clover Health Investments Corp.?
Andrew Toy is Clover Health Investments Corp.'s Chief Executive Officer.
How many directors are on Clover Health Investments Corp.'s board?
Clover Health Investments Corp.'s board has 11 directors: Andrew Toy, Anna U. Loengard, Brian James Miller, Carladenise Armbrister Edwards, Chelsea Clinton, Demetrios L. Kouzoukas, Lee Shapiro, Robert G. Torricelli, Thomas L. Tran, Vivek Garipalli and 1 other.
Are Clover Health Investments Corp. insiders buying or selling shares?
Over the last 12 months, Clover Health Investments Corp. insiders made no open-market purchases and sold $8.8 million of shares in 42 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="clover-health-investments-corp"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.